SafeSpace Global Begins Paid Deployment of AI Safety Platform at Antidote Health Facility
Event summary
- SafeSpace Global signed a 60-month Statement of Work with Antidote Health Ventures for initial paid deployment of its Behavioral Health safety platform at a Tennessee facility.
- The deployment follows a June 2026 Master Services Agreement and marks the first commercial implementation of SafeSpace's Addiction Treatment Vertical.
- The platform will provide monitoring, alerting, and AI-assisted capabilities tailored for behavioral health environments.
- Commercial pricing has been established for this initial deployment, with potential for expansion to additional facilities.
The big picture
This deployment represents a strategic shift from development to commercial implementation for SafeSpace's Addiction Treatment Vertical. The partnership with Antidote Health Ventures, an early-stage company with a vertically integrated recovery model, positions SafeSpace to address distinct safety challenges in behavioral health facilities. The success of this deployment could validate the market need for AI-assisted monitoring solutions in addiction treatment environments.
What we're watching
- Technology Refinement
- How operational learnings from this deployment will inform platform improvements for behavioral health environments.
- Market Expansion
- Whether SafeSpace can successfully scale this solution across the addiction treatment continuum.
- Commercial Viability
- The pace at which this initial deployment could lead to broader commercial agreements with Antidote.
Related topics
